Ultrasound Guided Axillary Venous Cannulation in Pediatrics

Not Applicable

Completed

• Conditions: Ultrasound Guided Central Venous Cannulation
• Interventions: Device: US_Ax; Device: landmark

• Registration Number: NCT02806401
• Lead Sponsor: Seoul National University Hospital

Brief Summary

The purpose of this prospective randomized study was to compare landmark-subclavian venous access to ultrasound-guided axillary venous access when performed by pediatric anesthesiologists.

Detailed Description

Objective: Subclavian vein catheterization may cause various complications. The investigators will compare the real-time ultrasound-guided axillary venous access vs. the landmark method- subclavian venous access in pediatric paticipants. (the needle insertion point of ultrasound-guided axillary venous is axillary vein. and the needle insertion point of landmark method is infraclavicular subclavian vein)

Design: Prospective randomized study.

Setting: Operating room of a tertiary medical center.

Interventions: The investigators will compare the ultrasound-guided axillary vein cannulation (66 paticipants) vs. the landmark method (66 pa- ticipants).

Study Timeline

• Study Start: 2016-06
• Study First Submitted: 2016-06-16
• Study First Submitted QC: 2016-06-16
• Study First Posted: 2016-06-20
• Primary Completion: 2017-05
• Study Completion: 2017-08
• Status Verified: 2018-09
• Last Update Submitted: 2018-09-05
• Last Update Posted: 2018-09-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 132

Inclusion Criteria

• surgery under general anesthesia require central venous catheterization

Exclusion Criteria

• hematoma in central vein central vein anomaly catheterization site infection

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
US_Ax	US_Ax	ultrasound guided axillary venous cannulation
landmark	landmark	landmark method_subclavian venous cannulation

Primary Outcome Measures

Name	Time	Method
2nd access success rate	interval between skin penetration and removal of the needle or catheter after central line insertion, an expected average of 120 seconds

Secondary Outcome Measures

Name	Time	Method
1st access success rate	interval between skin penetration and removal of the needle or catheter after central line insertion, an expected average of 120 seconds
3rd access success rate	interval between skin penetration and removal of the needle or catheter after central line insertion, an expected average of 120 seconds
total time	interval between skin penetration and removal of the needle or catheter after central line insertion, an expected average of 120 seconds

Trial Locations

Locations (1)

Jin-Tae Kim; 🇰🇷 Seoul, Korea, Republic of